Influence of age and shock severity on short-term survival in patients with cardiogenic shock.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
24 Aug 2021
Historique:
received: 01 09 2020
revised: 28 10 2020
accepted: 10 12 2020
pubmed: 14 2 2021
medline: 25 11 2021
entrez: 13 2 2021
Statut: ppublish

Résumé

Cardiogenic shock (CS) is associated with poor outcomes in older patients, but it remains unclear if this is due to higher shock severity. We sought to determine the associations between age and shock severity on mortality among patients with CS. Patients with a diagnosis of CS from Mayo Clinic (2007-15) and University Clinic Hamburg (2009-17) were subdivided by age. Shock severity was graded using the Society for Cardiovascular Angiography and Intervention (SCAI) shock stages. Predictors of 30-day survival were determined using Cox proportional-hazards analysis. We included 1749 patients (934 from Mayo Clinic and 815 from University Clinic Hamburg), with a mean age of 67.6 ± 14.6 years, including 33.6% females. Acute coronary syndrome was the cause of CS in 54.0%. The distribution of SCAI shock stages was 24.1%; C, 28.0%; D, 33.2%; and E, 14.8%. Older patients had similar overall shock severity, more co-morbidities, worse kidney function, and decreased use of mechanical circulatory support compared to younger patients. Overall 30-day survival was 53.3% and progressively decreased as age or SCAI shock stage increased, with a clear gradient towards lower 30-day survival as a function of increasing age and SCAI shock stage. Progressively older age groups had incrementally lower adjusted 30-day survival than patients aged <50 years. Older patients with CS have lower short-term survival, despite similar shock severity, with a high risk of death in older patients with more severe shock. Further research is needed to determine the optimal treatment strategies for older CS patients.

Identifiants

pubmed: 33580778
pii: 6062322
doi: 10.1093/ehjacc/zuaa035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-612

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Jacob C Jentzer (JC)

Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Benedikt Schrage (B)

Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), University Heart Centre Hamburg, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.

David R Holmes (DR)

Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Salim Dabboura (S)

Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), University Heart Centre Hamburg, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.

Nandan S Anavekar (NS)

Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Paulus Kirchhof (P)

Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), University Heart Centre Hamburg, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.

Gregory W Barsness (GW)

Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Stefan Blankenberg (S)

Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), University Heart Centre Hamburg, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.

Malcolm R Bell (MR)

Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Dirk Westermann (D)

Department of Interventional and General Cardiology, University Heart Centre Hamburg, Hamburg, Germany.
German Centre for Cardiovascular Research (DZHK), University Heart Centre Hamburg, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH